Pharmaceutial & Healthcare

This report studies Anti-decubitus Dynamic Mattresses in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Linet Talley Apex Medical Getting Group Hill-Rom Sidhil Malvestio By types, the market can be split into Foam Mattresses Air Cushion Mattresses Other Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-anti-decubitus-dynamic-mattresses-market-professional-survey-report-2017/request-sample By Application, the market can be split into Hospital Nursing Home Home Use By Regions, this report covers  North America China Europe Southeast Asia Japan India About Radiant Insights,Inc Radiant Insights is a p...

In this report, the global Paclitaxel Injection market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-paclitaxel-injection-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (L), revenue (Million USD), market share and growth rate of Paclitaxel Injection for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Paclitaxel Injection market competition by top manufacturers/players, with Paclitaxel Injection sales volume, Price (USD/L), revenue (Million USD) and market share for each manufacturer/player; the top players including Bristol-Myers Squibb Celgene Corporation Hospira Biological E. Taj Accura Khandelwal Laboratories On the basis on the en...

In this report, the global Orthopedic Consumables market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-orthopedic-consumables-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Orthopedic Consumables for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Orthopedic Consumables market competition by top manufacturers/players, with Orthopedic Consumables sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including DePuy Synthes Stryker Wright Medical Zimmer Biomet Medtronic 3M DSM Biomedical Biotek On the basis of pr...

In this report, the global Oncolytic Virus market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-oncolytic-virus-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Oncolytic Virus for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Oncolytic Virus market competition by top manufacturers/players, with Oncolytic Virus sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Merck Otsuka Pharmaceutical Co Pfizer Roche Cold Genesys On the basis of product, this report displays the production, revenue, price, ma...

In this report, the global Blood Serum market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-blood-serum-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Blood Serum for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Blood Serum market competition by top manufacturers/players, with Blood Serum sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including GE Healthcare Sigma-Aldrich Merck Corning Bioind Gemini Bovogen On the basis on the end users/applications, this report focuses on the status and outlook for ...

In this report, the global Bio-pharma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-bio-pharma-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Bio-pharma for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer F. Hoffmann-La Roche AG Johnson & Johnson Services Sanofi, Amgen AbbVie Merck & Co., Inc Biogen Idec Bayer AG Eli Lilly and Company On the basis o...

In this report, the global Asthma Treatment Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-asthma-treatment-drugs-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Asthma Treatment Drugs for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Asthma Treatment Drugs market competition by top manufacturers/players, with Asthma Treatment Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including GlaxoSmithKline Sanofi Roche & Novartis Teva Merck AstraZeneca Boehringer Ingelheim On the basis on...

This report studies sales (consumption) of Antidiabetic Thiazolidinediones in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Sanofi Takeda Pharmaceuticals Eli Lilly Merck & Co. Novo Nordisk Bristol-Myers Squibb Pfizer AstraZeneca GlaxoSmithKline Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-antidiabetic-thiazolidinediones-sales-market-report-2017/request-sample Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antidiabetic Thiazolidinediones in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Southeast Asia India Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type...

This report studies Avian Influenza Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Merial QYH Biotech DHN HVRI CEVA Elanco (Lohmann) Yebio Zoetis Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-avian-influenza-vaccines-industry-2017/request-sample Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Avian Influenza Vaccines in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by application, this report focuses on consumption, market share and growth rate of Avian Influenza Vaccines in each application, can be divided into Chicken Duck & Goose Other Browse ...

This report studies Antibacterial Drug Resistance in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering AAIPharma Services ANTABIO Abgentis Abbott Laboratories Absynth Biologics Achaogen Acino Holdings Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-antibacterial-drug-resistance-industry-2017/request-sample Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Antibacterial Drug Resistance in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by application, this report focuses on consumption, market share and growth rate of Antibacterial Drug Resistance in each application, can be divide...

In this report, the global Anti-Aging Products and Therapies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-anti-aging-products-and-therapies-industry-2017/request-sample Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-Aging Products and Therapies in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Anti-Aging Products and Therapies market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Allergan Ipsen Lanzhou Institute Corneal(Allergan) Galdermal LG Life Science Bohus BioTech IMEIK On the basis on the...

This report studies Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-intravenous-immunoglobulin-ivig-market-professional-survey-report-2017/request-sample This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Pfizer Baxter International, Inc. Bharat Serums and Vaccines Limited Biotest AG. China Biologic Products, Inc Guizhou Taibang Biological Products Co., Ltd CSL Limited CSL Behring LLC Grifols, S.A By types, the market can be split into IgG IgA IgM IgD IgE By Application, the market can be split into Disease Prevention Disease Treatment Disease Research Others By Regions, th...

In this report, the EMEA Sports Nutritional Supplements market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Sports Nutritional Supplements for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-sports-nutritional-supplements-industry-2017/request-sample EMEA Sports Nutritional Supplements market competition by top manufacturers/players, with Sports Nutritional Supplements sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each man...

In this report, the EMEA Scaffold Free 3D Cell Culture market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Scaffold Free 3D Cell Culture for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-scaffold-free-3d-cell-culture-industry-2017/request-sample EMEA Scaffold Free 3D Cell Culture market competition by top manufacturers/players, with Scaffold Free 3D Cell Culture sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each ma...

In this report, the EMEA Plant Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-plant-protein-industry-2017/request-sample Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Plant Protein for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Plant Protein market competition by top manufacturers/players, with Plant Protein sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Archer Daniels Midland Cargill DuPon...

In this report, the EMEA Ophthalmology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-ophthalmology-drugs-industry-2017/request-sample Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Ophthalmology Drugs for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Ophthalmology Drugs market competition by top manufacturers/players, with Ophthalmology Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Nova...

In this report, the EMEA Narcolepsy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-narcolepsy-therapeutics-industry-2017/request-sample Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Narcolepsy Therapeutics for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Narcolepsy Therapeutics market competition by top manufacturers/players, with Narcolepsy Therapeutics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top player...

In this report, the EMEA Hemoglobinopathies Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Hemoglobinopathies Drugs for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-hemoglobinopathies-drugs-industry-2017/request-sample EMEA Hemoglobinopathies Drugs market competition by top manufacturers/players, with Hemoglobinopathies Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top pla...

In this report, the global Scaffold Free 3D Cell Culture market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-scaffold-free-3d-cell-culture-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Scaffold Free 3D Cell Culture for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Scaffold Free 3D Cell Culture market competition by top manufacturers/players, with Scaffold Free 3D Cell Culture sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including InSphero N3d Biosciences Kuraray Hamilton Company Synthecon Qgel Sa On...

In this report, the global Ophthalmology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-ophthalmology-drugs-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Ophthalmology Drugs for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Ophthalmology Drugs market competition by top manufacturers/players, with Ophthalmology Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Novartis Regeneron Roche Bayer Allergan Shire Mallinckrodt On the basis on the end users/applications, this report focuse...

In this report, the global Narcolepsy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-narcolepsy-therapeutics-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Narcolepsy Therapeutics for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Narcolepsy Therapeutics market competition by top manufacturers/players, with Narcolepsy Therapeutics sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Addrenex Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd. Jazz Pharmaceuticals PLC Graymark He...

In this report, the global Hemoglobinopathies Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-hemoglobinopathies-drugs-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Hemoglobinopathies Drugs for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Hemoglobinopathies Drugs market competition by top manufacturers/players, with Hemoglobinopathies Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Gamida Cell Alnylam Pharmaceuticals Biogen Idec Sangamo BioSciences Inc. Genetix Pharmaceuticals/Blu...

In this report, the global Corneal Transplant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Corneal Transplant for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-corneal-transplant-sales-market-report-2017/request-sample Global Corneal Transplant market competition by top manufacturers/players, with Corneal Transplant sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including CryoLife, Inc. Exactech, Inc. Kohler GmbH Lifeline Scientific LIFECELL CORPORATION Medtronic On the basis on the end users...

In this report, the global Acute Heart Failure (AHF) Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-acute-heart-failure-ahf-therapeutics-sales-market-report-2017/request-sample Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acute Heart Failure (AHF) Therapeutics for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Acute Heart Failure (AHF) Therapeutics market competition by top manufacturers/players, with Acute Heart Failure (AHF) Therapeutics sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Bayer AG Bristol-Myers Squibb Company...

In this report, the global Non-Tyrosine Kinase Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-non-tyrosine-kinase-inhibitors-industry-2017/request-sample Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Non-Tyrosine Kinase Inhibitors in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Non-Tyrosine Kinase Inhibitors market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Roche Eli Lilly Novartis Array BioPharma Nerviano Medical Sciences Pfizer Merck KGaA On the basis of the end users/applications, t...

In this report, the global Blood-Brain Barrier Transport Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-blood-brain-barrier-transport-drugs-industry-2017/request-sample Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Blood-Brain Barrier Transport Drugs in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Blood-Brain Barrier Transport Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Cyclenium BioAdvance EIP Pharma Bioasis Immune Pharmaceuticals AZ Therapies Palobiofarma Bach Pharma Browse ...

In this report, the EMEA Glycosylated Hemoglobin and C-Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Glycosylated Hemoglobin and C-Peptide for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-glycosylated-hemoglobin-and-c-peptide-industry-2017/request-sample EMEA Glycosylated Hemoglobin and C-Peptide market competition by top manufacturers/players, with Glycosylated Hemoglobin and C-Peptide sales volume (MT), price (USD/Kg), revenue (Million US...